Financials 10x Genomics, Inc.

Equities

TXG

US88025U1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 20:00:00 10/03/2026 GMT			5-day change	1st Jan Change
20.46 ^USD	-2.15%		-9.55%	+25.44%

02-20	UBS Adjusts Price Target on 10x Genomics to $20 From $14, Maintains Neutral Rating	MT
02-12	10x Genomics, Inc., Q4 2025 Earnings Call, Feb 12, 2026

Projected Income Statement: 10x Genomics, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	490.5	516.4	618.7	610.8	642.8	613.3	657.8	709.8
Change	-	5.28%	19.81%	-1.28%	5.25%	-4.59%	7.25%	7.9%
EBITDA ¹	-31.14	-142.6	-229.8	-158.7	-74.69	-93.24	-73.52	-45.97
Change	-	-357.93%	-61.19%	30.95%	52.93%	-24.84%	21.14%	37.48%
EBIT ¹	-52.91	-167.9	-265.3	-194.6	-110.9	-128.5	-99.86	-74.18
Change	-	-217.4%	-57.99%	26.67%	43.01%	-15.86%	22.27%	25.72%
Interest Paid ¹	-0.66	-0.476	-0.033	-0.004	20.05	-12	-12	-8
Earnings before Tax (EBT) ¹	-53.72	-162	-248.8	-177.7	-39.91	-119.1	-92.06	-85.75
Change	-	-201.54%	-53.58%	28.57%	77.54%	-198.55%	22.73%	6.86%
Net income ¹	-58.22	-166	-255.1	-182.6	-43.54	-121.4	-96.23	-64.55
Change	-	-185.11%	-53.67%	28.41%	76.16%	-178.87%	20.75%	32.93%
Announcement Date	16/02/22	15/02/23	15/02/24	12/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	105.8	115.8	125.3	143.5	114.5	114.6	131.1	156.2	134.3	146.8	153.6	184	141	153.1	151.7	165	154.9	172.9	149	166	146.3	148.4	153	165.7	155.5	160	165.1	177.7
Change	-	9.47%	8.16%	14.55%	-20.23%	0.1%	14.36%	19.2%	-14.05%	9.33%	4.65%	19.74%	-23.36%	8.58%	-0.95%	8.81%	-6.14%	11.64%	-13.83%	11.43%	-11.87%	1.4%	3.1%	8.35%	-6.19%	2.94%	3.19%	7.59%
EBITDA ¹	-5.274	-5.439	-10.18	-10.05	-35.54	-56.62	-33.84	-16.58	-45.51	-53.42	-85.42	-45.47	-52.3	-32.77	-32.52	-41.09	-31.31	37.94	-21.94	-9.476	-33.15	-24.66	-23.94	-14.35	-24.65	-15.08	-21.58	-13.71
Change	-	-3.13%	-87.22%	1.32%	-253.71%	-59.29%	40.23%	51.02%	-174.55%	-17.38%	-59.92%	46.77%	-15.03%	37.35%	0.75%	-26.35%	23.81%	221.19%	-157.84%	56.82%	-249.82%	25.6%	2.92%	40.07%	-71.77%	38.82%	-43.12%	36.49%
EBIT ¹	-10.22	-11.18	-15.88	-15.83	-41.74	-63.12	-40	-23.1	-51.99	-63.36	-94.8	-55.19	-61.5	-41.74	-41.48	-49.84	-48.53	30.13	-32.24	-19.54	-40.1	-33.59	-31.64	-23.78	-34.45	-25.89	-24.51	-18.6
Change	-	-9.42%	-42.06%	0.31%	-163.64%	-51.23%	36.63%	42.25%	-125.1%	-21.87%	-49.62%	41.78%	-11.43%	32.13%	0.6%	-20.14%	2.63%	162.08%	-207.02%	39.39%	-105.21%	16.22%	5.82%	24.84%	-44.85%	24.85%	5.31%	24.11%
Charge d'intérêts ¹	-0.171	-0.151	-0.17	-0.168	0.441	1.129	1.911	-0.125	-0.019	-0.005	-0.001	-0.008	-0.001	4.714	4.969	-	-	-4.268	5.196	5.492	-3	-3	-3	-3	-3	-3	-3	-3
Earnings before Tax (EBT) ¹	-11.12	-9.958	-16.65	-15.99	-41.69	-63.83	-40.04	-16.41	-49.65	-60.77	-91.74	-46.6	-57.8	-37.08	-34.44	-48.38	-33.51	37	-28.2	-15.19	-37.6	-31.51	-29.71	-22.36	-31.9	-23.34	-21.96	-15.06
Change	-	10.42%	-67.18%	3.93%	-160.7%	-53.09%	37.28%	59.01%	-202.57%	-22.38%	-50.98%	49.21%	-24.05%	35.85%	7.12%	-40.48%	30.74%	210.42%	-176.24%	46.13%	-147.51%	16.21%	5.7%	24.74%	-42.63%	26.82%	5.94%	31.39%
Net income ¹	-11.55	-11.05	-17.17	-18.45	-42.41	-64.46	-41.91	-17.22	-50.75	-62.41	-92.99	-48.95	-59.95	-37.9	-35.75	-49.03	-34.36	34.54	-27.47	-16.25	-37.69	-32.51	-30.25	-22.9	-31.11	-23.02	-21.32	-14.83
Change	-	4.32%	-55.37%	-7.44%	-129.89%	-51.98%	34.97%	58.93%	-194.78%	-22.99%	-48.98%	47.36%	-22.46%	36.78%	5.66%	-37.13%	29.92%	200.52%	-179.54%	40.84%	-131.89%	13.75%	6.93%	24.32%	-35.86%	25.99%	7.41%	30.42%
Announcement Date	05/05/21	04/08/21	03/11/21	16/02/22	04/05/22	08/08/22	02/11/22	15/02/23	03/05/23	03/08/23	02/11/23	15/02/24	30/04/24	08/08/24	29/10/24	12/02/25	08/05/25	07/08/25	06/11/25	12/02/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: 10x Genomics, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-587	-430	-389	-393	-523	-484	-526	-590
Change	-	26.75%	9.53%	-1.03%	-33.08%	7.53%	-8.68%	-12.17%
Announcement Date	16/02/22	15/02/23	15/02/24	12/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: 10x Genomics, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	101.3	131.7	48.6	12.39	5.935	10.04	10.63	10.6
Change	-	30%	-63.09%	-74.5%	-52.11%	69.22%	5.85%	-0.26%
Free Cash Flow (FCF) ¹	-122.7	-165.3	-63.8	-5.729	130.1	-36	-8	25
Change	-	-34.75%	61.4%	91.02%	2,371.16%	-127.67%	77.78%	412.5%
Announcement Date	16/02/22	15/02/23	15/02/24	12/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: 10x Genomics, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-6.35%	-27.61%	-37.14%	-25.98%	-11.62%	-15.2%	-11.18%	-6.48%
EBIT Margin (%)	-10.79%	-32.52%	-42.88%	-31.85%	-17.25%	-20.95%	-15.18%	-10.45%
EBT Margin (%)	-10.95%	-31.36%	-40.21%	-29.09%	-6.21%	-19.43%	-13.99%	-12.08%
Net margin (%)	-11.87%	-32.15%	-41.23%	-29.9%	-6.77%	-19.8%	-14.63%	-9.09%
FCF margin (%)	-25.01%	-32%	-10.31%	-0.94%	20.24%	-5.87%	-1.22%	3.52%
FCF / Net Income (%)	210.66%	99.56%	25.01%	3.14%	-298.81%	29.65%	8.31%	-38.73%
Profitability
ROA	-5.98%	-16.21%	-25.59%	-19.39%	-4.44%	-10.92%	-9.98%	-7.75%
ROE	-7.48%	-20.45%	-32.98%	-25.17%	-5.78%	-14%	-11.79%	-10.45%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	20.65%	25.5%	7.85%	2.03%	0.92%	1.64%	1.62%	1.49%
CAPEX / EBITDA (%)	-325.29%	-92.34%	-21.15%	-7.81%	-7.95%	-10.77%	-14.46%	-23.07%
CAPEX / FCF (%)	-82.57%	-79.67%	-76.18%	-216.32%	4.56%	-27.9%	-132.88%	42.41%
Items per share
Cash flow per share ¹	-0.1937	-0.2952	-0.1297	0.0553	1.091	0.8677	1.195	0.3844
Change	-	-52.4%	56.06%	142.64%	1,872.15%	-20.44%	37.7%	-67.83%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	7.266	6.995	6.218	5.807	6.236	6.194	6.228	6.472
Change	-	-3.74%	-11.1%	-6.62%	7.39%	-0.68%	0.55%	3.92%
EPS ¹	-0.53	-1.46	-2.18	-1.52	-0.35	-0.9692	-0.7623	-0.4998
Change	-	-175.47%	-49.32%	30.28%	76.97%	-176.91%	21.35%	34.43%
Nbr of stocks (in thousands)	111,707	114,464	118,209	121,054	126,553	127,752	127,752	127,752
Announcement Date	16/02/22	15/02/23	15/02/24	12/02/25	12/02/26	-	-	-